About this trial
The aim for thid study is to detect the prevalence of HSPM and the possible association between MIH and HSPM in a group of Egyptian children aged from 6-12 years. The study will also observe the possible etiological factors that might predispose hypomineralization of primary teeth.
To our knowledge, there are no relevant studies that considered the prevalence of HSPM and its possible etiology in Egypt or its association with MIH. So, this study will address this knowledge gap. The possible relationship between HSPM and MIH is highly significant in pediatric dentistry, since the early diagnosis of HSPM as soon as second primary molars erupt makes it possible to initiate more intensive supervision and preventive measures, as these patients are otherwise prone to developing MIH in permanent teeth within a few years.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Both genders will be included
Children and adolescents with age group from 6-12 years
Participants who agreed to sign rhe informed consent
Disqualifiers
Patients having enamel defects like fluorosis, amelogenesis imperfecta and dentinogenesis imperfecta
Special health care needs
Non-Egyptian children
Trial population
The study will be done on pediatric patients with the age between 6-12 years old, attending outpatient clinic in the Department of Pediatric Dentistry and Public Health, Cairo university.
Trial design
Case-control
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Prevalence of HSPM in a group of Egyptian children using EAPD scoring criteria
Prevalence of Hypomineralized Second Primary Molars in a group of Egyptian children using EAPD (European Academy of Pediatric Dentistry) scoring criteria
Secondary outcomes
Correlation of HSPM with MIH
Correlation of Hypomineralized Second Primary Molars with Molar Incisor Hypomineralization using binary outcome (Present/Absent)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: